Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Radiology Imaging | November 01, 2016

Real Systems Not Available: Punch Line or Prophecy?

imaging

For a long time, the ongoing joke on the floor of the McCormick Place after Thanksgiving was that RSNA stood for Real Systems Not Available. And, like all humor that lasts, there is truth to it. But that truth is changing. 

The joke took root maybe 20 years ago with vendors who spent a lot of time talking about what would begin shipping in the second or third quarter of next year. Or later.

Those were the days of slice wars, when Siemens, GE, Philips and Toshiba talked about computed tomography (CT) scanners with double the slices of what was then on the market. Four became eight; eight became 16; 16 became 32. And so on, stretching back to the quad CTs unveiled in 1998 and forward to the mid-2000s when 64-slice mania peaked. 

Or maybe it was before then. Maybe it was the 1980s, when ultrasound vendors Diasonics, ATL and Acuson battled over digital platforms; debated the relative worth of more channels; and whether one or the other platform was better at color Doppler. Or harmonic imaging. Or …

Digital flat panels popped up in the mid-1990s amid rancor about which delivered better quality — ones that recorded X-ray photons directly or indirectly. Selenium? Cesium iodide or gadolinium oxysulfide?

Computed radiography was supposed to be a stepping-stone to the digital future, a handmaiden to the flat panel. Who knew it would flourish in the mainstream for 20 years?

Changing Competition

Through those raucous times, vaporware was king. Works in progress were how vendors showed that their R&D programs were state-of-the-art. But the works proliferated. And product deliveries stretched on. And that upset some people.

There was a disconcerting din, comprised of hype and hullabaloo. The noise has since diminished. The hype has quieted down. And the once cacophonous unveiling of works in progress has tamed. More real systems are available compared to works in progress, and that trend will likely continue. The reasons are several.

For one, competition has gone down. A lot. The upstarts have been bought or consolidated. ATL, Diasonics and Acuson are gone. Ditto Bennett X-Ray, Lorad, Fischer and dozens of others. The market has matured. But it’s more than simple maturity.

Market dynamics have changed radically. New technology sold many times because it gave a provider an edge over its competitors. But today keeping up with the St. Joneses no longer is as important as staying within budget at many facilities. Vendors will continue to show works in progress. But the reasons they do so will be much different than before. 

Whereas in the past a work-in-progress might have been unveiled with the goal of stalling the market — making prospective buyers wait until the new product was available — the more likely reason today and from now on is to help current sales. How? By assuring customers they can buy with confidence that the company’s R&D is moving in the right direction.

Crystal Balls of What Will Come

Works in progress will be unveiled at the coming RSNA, no doubt about it. But there will be fewer than a decade ago. And they could have much more to say about the future of radiology. 

If a vendor can develop products that satisfy certain needs — efficiency and cost effectiveness, for example — might those products determine how medicine will be practiced in the future? And if the C-suite is making decisions about the tools to be put in physicians’ hands, will efficiency and cost effectiveness determine future medical practice?

Will works in progress grease the skids to a future in which radiologists are part of patient management teams? Or will the adoption of fledgling products relegate radiologists to past roles in diagnosis?

Put a shovel in a man’s hands and he will dig. People do what tools allow them to do.

Today’s works in progress, therefore, may have far greater significance than the works of progress that preceded them. They are coming in fewer numbers. The ones vendors highlight will not be iterative advances of existing platforms. They will embody the vision that their maker has of the future.   

As we move forward into the uncharted seas of value-based medicine, “real systems are not available” may not be punch line so much as prophecy.

They may be the crystal balls through which the future will be seen.

 

Editor’s note: This column is the culmination of a series of four blogs by industry consultant Greg Freiherr on State-of-the-Art Radiology. The blogs can be found at www.itnonline.com/content/state-art-radiology.

Related Content

Philips and The Walt Disney Company EMEA announced they are teaming up to test the effects of custom-made animation, including specially-made Disney stories, within Philips Ambient Experience, a solution that integrates architecture, design and enabling technologies, such as dynamic lighting, video projections and sound, to allow patients and staff to personalize their environment to create a relaxing atmosphere

Study will explore the effects and use of animated stories and characters, including Disney favorites, as part of Philips Ambient Experience solution.

News | Magnetic Resonance Imaging (MRI) | March 03, 2021
March 3, 2021 — ...
A single image of a human brain using a magnetic resonance imaging (MRI) machine. Image courtesy of Dr Leon Kaufman. University Of California, San Francisco

A single image of a human brain using a magnetic resonance imaging (MRI) machine. Image courtesy of Dr Leon Kaufman. University Of California, San Francisco

News | Ultrasound Imaging | March 03, 2021
March 3, 2021 — A type of ultrasound scan can detect
Researchers said women who skip even one scheduled mammography screening before a breast cancer diagnosis face a significantly higher risk of dying from the cancer.

Getty Images

News | Mammography | March 03, 2021
March 3, 2021 — Attendance at regular ...
A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients.

A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients. Image courtesy of Caylie Silveria/West Virginia University

News | Focused Ultrasound Therapy | March 02, 2021
March 2, 2021 — West Virginia University scientists used...
Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in t
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned. #COVIDvaccine #COVID19

55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

News | Breast Imaging | February 24, 2021